NEVRO CORP. Net Change in Cash
NEVRO CORP. reported Net Change in Cash of -$9.77 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-04.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2025-03-04
- NEVRO CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was -$13.91M.
- NEVRO CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$56.15M, a 480.37% decline year-over-year.
- NEVRO CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was $14.76M, a 64.80% decline year-over-year.
- NEVRO CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-03-31 was $41.94M, a 40.87% decline year-over-year.
- NEVRO CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was -$9.77M.
- NEVRO CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was -$16.16M, a 118.86% decline from fiscal 2022.
- NEVRO CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was $85.66M.
- NEVRO CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was -$9.89M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$9.77M 10-K · filed 2025-03-04 | |||
| 2024-09-30 | -$32.23M 10-Q · filed 2024-11-12 | |||
| 2024-06-30 | -$29.52M 10-Q · filed 2024-08-06 | |||
| 2024-03-31 | -$13.91M 10-Q · filed 2024-05-07 | |||
| 2023-12-31 | -$16.16M 10-K · filed 2025-03-04 | |||
| 2023-09-30 | -$55.22M 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | -$55.19M 10-Q · filed 2024-08-06 | |||
| 2023-03-31 | -$56.15M 10-Q · filed 2024-05-07 | |||
| 2022-12-31 | $85.66M 10-K · filed 2025-03-04 | |||
| 2022-09-30 | $96.13M 10-Q · filed 2023-11-01 | |||
| 2022-06-30 | $74.30M 10-Q · filed 2023-08-01 | |||
| 2022-03-31 | $14.76M 10-Q · filed 2023-04-26 | |||
| 2021-12-31 | -$9.89M 10-K · filed 2024-02-23 | |||
| 2021-09-30 | $36.29M 10-Q · filed 2022-11-02 | |||
| 2021-06-30 | $101.42M 10-Q · filed 2022-08-03 | |||
| 2021-03-31 | $41.94M 10-Q · filed 2022-05-04 | |||
| 2020-12-31 | -$21.13M 10-K · filed 2023-02-21 | |||
| 2020-09-30 | $53.26M 10-Q · filed 2021-11-08 | |||
| 2020-06-30 | $211.14M 10-Q · filed 2021-08-04 | |||
| 2020-03-31 | $70.92M 10-Q · filed 2021-05-05 | |||
| 2019-12-31 | $14.46M 10-K · filed 2022-02-23 | |||
| 2019-09-30 | -$1.58M 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | $11.55M 10-Q · filed 2020-08-05 | |||
| 2019-03-31 | -$10.56M 10-Q · filed 2020-05-05 | |||
| 2018-12-31 | $8.22M 10-K · filed 2021-02-24 | |||
| 2018-09-30 | -$21.67M 10-Q · filed 2019-11-06 | |||
| 2018-06-30 | -$2.01M 10-Q · filed 2019-08-08 | |||
| 2018-03-31 | -$15.20M 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $1.44M 10-K · filed 2020-02-25 | |||
| 2017-09-30 | $2.64M 10-Q · filed 2018-11-05 | |||
| 2017-06-30 | -$16.54M 10-Q · filed 2018-08-02 | |||
| 2017-03-31 | -$22.21M 10-Q · filed 2018-05-07 | |||
| 2016-12-31 | -$45.73M 10-K · filed 2019-02-21 |